🇺🇸 FDA
Pipeline program

AZD5004, Placebo to match AZD5004 film coated tablet, AZD5004, AZD5004

D7260C00001

Phase 2 small_molecule active

Quick answer

AZD5004, Placebo to match AZD5004 film coated tablet, AZD5004, AZD5004 for Participants living with Obesity or Overweight with at least 1 comorbidity is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Participants living with Obesity or Overweight with at least 1 comorbidity
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials